FindTrial
Sign In

The effect of alprostadil on renal function after renal ischemia reperfusion

The effect of alprostadil on renal function after renal ischemia reperfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002008
Enrollment
Unknown
Registered
2012-03-08
Start date
2011-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal carcinoma

Interventions

Control group:venous continous infusion intralipid
Alprostadil group:venuous continuous infusion alprostadil

Sponsors

Cancer Center, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with renal carcinoma undergoing hemiephrectomy; 2. above 18 years old.

Exclusion criteria

Exclusion criteria: allergic to alprostadil

Design outcomes

Primary

MeasureTime frame
creatine;ß2 microglobulin;Cystatin;—

Countries

China

Contacts

Public ContactZeng weian
zwngwa@sysucc.org.cn+86 20 87343060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026